Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
Ganna Balagura,1,2 Antonella Riva,2 Francesca Marchese,2 Alberto Verrotti,3 Pasquale Striano1,2 1Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health, University of Genoa, Genoa, Italy; 2Pediatric Neurology and Muscular Diseases Unit, IRCCS ‘G...
Guardado en:
Autores principales: | Balagura G, Riva A, Marchese F, Verrotti A, Striano P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/150e9af6e1924893a4ea1ddfc95c12ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rufinamide in patients with Lennox-Gastaut syndrome
por: Clark PO, et al.
Publicado: (2016) -
Truncating mutation in TANC2 in a Chinese boy associated with Lennox-Gastaut syndrome: a case report
por: Yang Tian, et al.
Publicado: (2021) -
Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
por: Ostendorf AP, et al.
Publicado: (2017) -
Case Report: Lennox–Gastaut Epileptic Encephalopathy Responsive to Cannabidiol Treatment Associated With a Novel de novo Mosaic SHANK1 Variant
por: Justyna Paprocka, et al.
Publicado: (2021) -
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
por: Carl E Stafstrom
Publicado: (2009)